Evaluation of Cross-Immunity to the Mpox Virus Due to Historic Smallpox Vaccination

When the Mpox virus (MPXV) began spreading globally in 2022, it became critical to evaluate whether residual immunity from smallpox vaccination provided cross-protection. To assess the cross-immune response to MPXV, we collected serum samples (n = 97) and PBMCs (n = 30) from healthy-donors, either b...

Descripción completa

Detalles Bibliográficos
Autores principales: Matusali, Giulia, Petruccioli, Elisa, Cimini, Eleonora, Colavita, Francesca, Bettini, Aurora, Tartaglia, Eleonora, Sbarra, Settimia, Meschi, Silvia, Lapa, Daniele, Francalancia, Massimo, Bordi, Licia, Mazzotta, Valentina, Coen, Sabrina, Mizzoni, Klizia, Beccacece, Alessia, Nicastri, Emanuele, Pierelli, Luca, Antinori, Andrea, Girardi, Enrico, Vaia, Francesco, Sette, Alessandro, Grifoni, Alba, Goletti, Delia, Puro, Vincenzo, Maggi, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610801/
https://www.ncbi.nlm.nih.gov/pubmed/37896943
http://dx.doi.org/10.3390/vaccines11101541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610801/
https://www.ncbi.nlm.nih.gov/pubmed/37896943
http://dx.doi.org/10.3390/vaccines11101541

Ejemplares similares